<DOC>
	<DOCNO>NCT00265330</DOCNO>
	<brief_summary>The purpose study assess safety tolerability ziprasidone long-term open-label administration child adolescent ( age 10-17 ) bipolar I disorder ( manic mixed )</brief_summary>
	<brief_title>Safety Tolerability Ziprasidone Children Adolescents With Bipolar I Disorder ( Manic Mixed )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<criteria>Participation doubleblind treatment study A1281132 , meet specific criterion duration safety Imminent risk suicide homicide , judge site investigator ; serious adverse event relate study medication study A1281132 ; significant prolongation QT interval study A1281132 .</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>Children And Adolescents With Bipolar I Disorder ( Manic Or Mixed )</keyword>
</DOC>